At a glance
- Originator Nonindustrial source
- Class Caffeic acids; Heart failure therapies; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Beta 1 adrenergic receptor antagonists; Beta 2 adrenergic receptor agonists; Beta 2 adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 27 Jan 2000 New profile
- 27 Jan 2000 Preclinical development for Heart failure in Taiwan (Unknown route)